Therapeutic effect of a histamine H2 receptor antagonist on proton pump inhibitor-resistant symptomatic chronic gastritis

Therapeutic effect of a histamine H2 receptor antagonist on proton pump inhibitor-resistant symptomatic chronic gastritis - medical treatment of chronic gastritis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002247

Enrollment

Registered

2009-08-01

Start date

2009-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronica gastritis

Interventions

famotidine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: PPI-resistant patients with chronic gastritis

Exclusion criteria

Exclusion criteria: allergy to famotidine with serious diseases pregnant or lactating female

Design outcomes

Primary

Measure	Time frame
symptom	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026